-
Brain mechanism reveals in mice how food aroma primes metabolism and may explain obesity risk
Medical Mythbusting Commentary for June 10, 2026 Source:Brain mechanism reveals how food aroma primes metabolism and may explain obesity risk Reference:Glycogen drives the sensory activation of POMC neurons
-
Minimally invasive sleeve gastroscopy weight loss procedure being used at Royal Alexandria Hospital
Medical Mythbusting Commentary for May 29, 2026 Source:New weight loss procedure at Royal Alexandra Hospital being hailed a ‘game-changer’ Reference:Endoscopic sleeve gastroplasty (ESG), GLP-1 receptor agonists, and bariatric surgery each offer distinct risk-benefit profiles, and the optimal choice depends on obesity class, patient preferences, comorbidities, and willingness to commit to long-term pharmacotherapy. Below is a…
-
Can being significantly underweight be more damaging than overweight? Many factors not addressed in this body-mass-index observational study of 85K people of mean age of 66.4 years.
Medical Mythbusting Commentary for September 18, 2025 Source:Being too thin can be deadlier than being overweight, Danish study reveals
-
Pfizer ends development of weight-loss pill danuglipron
Medical Mythbusting Commentary for April 16, 2025 Source:Pfizer ends development of weight-loss pill danuglipron
-
New recommendations to measure obesity are more helpful than using only body mass index or BMI
Medical Mythbusting Commentary for January 22, 2025 Source:BMI is wrong way to measure obesity, researchers say — here’s what they recommend instead
-
In an act that signifies panic mode, processed food manufacturers like Nestle are launching products directed towards people who are using weight-loss medications as their collective reduction in appetite is biting into sales.
Medical Mythbusting Commentary for December 24, 2024 Source:Nestle launches protein shots for U.S. weight-loss drug users
-
Metabolically-active visceral abdominal fat linked to signs of Alzheimer’s. However, given its propensity to contribute to heart disease and diabetes risk, these factors are likely a major contributing factor too.
Medical Mythbusting Commentary for December 3, 2024 Source:Belly fat linked to signs of Alzheimer’s 20 years before symptoms begin, study says
-
Wegovy (semaglutide) now approved by Health Canada to reduce the risk of non-fatal heart attack in people with known cardiovascular disease in addition to its use for weight loss management.
Medical Mythbusting Commentary for November 28, 2024 Source:Wegovy is a weight-loss drug. Health Canada says it can now be used to curb heart-attack risk
-
Having “skinny genes” does not imply that stable weight and health are a given. Nor did the study provide conclusive proof that they play a major role in weight stability.
Medical Mythbusting Commentary for October 22, 2024 Source:Does having ‘skinny genes’ mean you can skip exercise and diet? Reference:Genotypic Variations Associated with Changes in Body Mass in Response to Endurance Training